Potential role of phytochemicals as glucagon-like peptide 1 receptor (GLP-1R) agonists in the treatment of diabetes mellitus
Mounjaro (tirzepatide) injection still leads on magnitude, with around 20% average weight loss at the highest dose when paired with lifestyle support
Available from: J L Sievenpiper 1 2 3 , J Ard 4 , M Blher 5 , W Chen 6 , J B Dixon 7 , A Fitch 8 , L Gigliotti 9 , K Khunti 10 , A Lecube 11 12 , M E J Lean 13 , B Mittendorfer 14 , A F H Pfeiffer 15 , D H Ryan 16 , T Vilsbll 17 18 , L F Van Gaal 19
For comprehensive resources and the latest research, visit Diabetes in Control
Wegovy has shown remarkable effectiveness in promoting weight loss, with participants in clinical trials experiencing an average weight reduction of around 15% of their initial body weight
ORAL GLP-1 UPDATE Kailera/Hengruis HRS-7535 showed 9.8% weight loss in a 44-week Phase 3 trial in China